Publishing high quality, peer reviewed original research and reviews addressing all aspects of basic biology and clinical use of haemopoietic cell transplantation. Official journal of the EBMT.
Our reviewers are essential in supporting the publication process of BMT. Their knowledge and critical evaluation is key and always appreciated. To show our thanks, we present here the profiles those awarded our 'top reviewer' accolade in 2022.
In this collection we highlight a selection of articles from 2022, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo).
Trending - Altmetric
Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT
Palliative care in BMT
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT